Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and antitumor agents. Its structure supports the design of targeted therapies in oncology due to the electron-withdrawing properties of fluorine atoms and the reactivity of the bromine moiety, enabling selective cross-coupling reactions. Commonly employed in medicinal chemistry for constructing quinoline-based bioactive molecules with improved metabolic stability and binding affinity.